Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer

Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Mitchell E. Gross, Jacek Pinski, David I. Quinn

Clinical Nuclear Medicine · 2012 · 137 citations · 12 references

DOIFull text

Open access

Abstract

In biochemical relapse of prostate cancer, 18 F-NaF PET/CT is useful in the detection of occult osseous metastases, whereas the yield of 18F-FDG PET/CT is relatively limited. 18F-NaF PET/CT positivity tends to associate with increasing PSA level in prostatectomized men and may occur in lower PSA ranges than conventionally recognized.

References

12